LIPO
Lipella Pharmaceuticals Inc

2,058
Loading...
Loading...
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Lipella Pharmaceuticals Inc?
What is the 52-week high for Lipella Pharmaceuticals Inc?
What is the 52-week low for Lipella Pharmaceuticals Inc?
What is Lipella Pharmaceuticals Inc stock price today?
What was Lipella Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Lipella Pharmaceuticals Inc?
What is the Price-to-Book ratio of Lipella Pharmaceuticals Inc?
What is the 50-day moving average of Lipella Pharmaceuticals Inc?
How many employess does Lipella Pharmaceuticals Inc has?

Latest LIPO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.